ES2070266T3 - Vacuna contra la infeccion por escherichia coli. - Google Patents

Vacuna contra la infeccion por escherichia coli.

Info

Publication number
ES2070266T3
ES2070266T3 ES90201990T ES90201990T ES2070266T3 ES 2070266 T3 ES2070266 T3 ES 2070266T3 ES 90201990 T ES90201990 T ES 90201990T ES 90201990 T ES90201990 T ES 90201990T ES 2070266 T3 ES2070266 T3 ES 2070266T3
Authority
ES
Spain
Prior art keywords
escherichia coli
vaccine against
against infection
toxin
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201990T
Other languages
English (en)
Spanish (es)
Inventor
Den Bosch Johannes Francis Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2070266T3 publication Critical patent/ES2070266T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES90201990T 1989-08-18 1990-07-23 Vacuna contra la infeccion por escherichia coli. Expired - Lifetime ES2070266T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
ES2070266T3 true ES2070266T3 (es) 1995-06-01

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201990T Expired - Lifetime ES2070266T3 (es) 1989-08-18 1990-07-23 Vacuna contra la infeccion por escherichia coli.

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
CN101273133A (zh) * 2005-08-30 2008-09-24 联邦科学工业研究组织 生物活性多肽的细菌传送
EP2355860B1 (en) 2009-10-12 2018-11-21 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
BR112012008682A2 (pt) 2009-10-12 2017-06-20 New Health Sciences Inc "dispositivo de depleção de oxigênio, e, método para remover oxigênio de células vermelhas do sangue."
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP4091645A1 (en) 2010-08-25 2022-11-23 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
PT3539381T (pt) 2010-11-05 2023-09-26 Hemanext Inc Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
ES2742949T3 (es) 2011-08-10 2020-02-17 New Health Sciences Inc Dispositivo integrado de filtrado para el agotamiento de leucocitos, oxígeno y/o co2 y separación de plasma
WO2014134503A1 (en) 2013-02-28 2014-09-04 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
CN107530377B (zh) 2015-03-10 2021-09-03 新健康科学股份有限公司 氧减少一次性套件、装置及其使用方法
CA2983295C (en) 2015-04-23 2024-02-13 New Health Sciences, Inc. Anaerobic blood storage containers
EP3297641B1 (en) 2015-05-18 2025-07-09 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
PT3463466T (pt) 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
US4886748A (en) * 1986-03-11 1989-12-12 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Also Published As

Publication number Publication date
DE69016129T2 (de) 1995-05-24
CA2022420C (en) 2000-03-28
US5750115A (en) 1998-05-12
HUT59612A (en) 1992-06-29
DE69016129D1 (de) 1995-03-02
AU635062B2 (en) 1993-03-11
CA2022420A1 (en) 1991-02-19
TW204353B (enExample) 1993-04-21
EP0413378B1 (en) 1995-01-18
CN1049523A (zh) 1991-02-27
EP0413378A1 (en) 1991-02-20
GR3015782T3 (en) 1995-07-31
HU211827A9 (en) 1995-12-28
IL95175A (en) 1994-05-30
IL95175A0 (en) 1991-06-10
AU6109990A (en) 1991-02-21
KR0177510B1 (ko) 1999-03-20
NZ234933A (en) 1992-06-25
DK0413378T3 (da) 1995-05-15
JPH03184996A (ja) 1991-08-12
HU905053D0 (en) 1991-01-28
CN1062605C (zh) 2001-02-28
JP3031561B2 (ja) 2000-04-10
HU210965B (en) 1995-09-28
KR910004209A (ko) 1991-03-28
ZA906100B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
PA8549701A1 (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
ATE350057T1 (de) Impfstoffzusammesetzung
ES2160601T3 (es) Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
PA8549801A1 (es) Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
AR020084A1 (es) Pestivirus atenuados
BR0110278A (pt) Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2058100T3 (es) Vacuna combinada.
PT894500E (pt) Vacina para streptococcus equi
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
ES2089371T3 (es) Vacuna contra las enfermedades respiratorias para gatos.
DK0623170T3 (da) Vacciner baseret på streptokinase
BR9305075A (pt) Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
NO953311L (no) Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413378

Country of ref document: ES